Skip to main content
. 2012 Jul;67(7):739–743. doi: 10.6061/clinics/2012(07)06

Table 1.

A comparative analysis of patient demographic, medical history, and clinical and laboratory data.

Present study SITS-ISTR p-value
Female sex 47.8% 39.7% 0.083
Hypertension 80.5% 59.2% 0.007
Diabetes mellitus 31.9% 16.0% <0.001
Hyperlipidemia 21.2% 35.1% 0.002
Obesity 23.9% NA -
Smoking 28.3% 25.6% 0.517
Alcohol abuse 17.7% NA -
Atrial fibrillation 16.8% 22.9% 0.144
Congestive heart failure 15.0% 7.6% 0.007
Ischemic heart disease 16.8% NA -
Prior stroke 18.6% 10.3% 0.003
Chagas' disease 5.3% NA -
Current aspirin use 29.2% 29.4% 0.999
Current warfarin use 6.2% NA -
Current statin use 8.8% NA -
SBP (mmHg) 156 (140-180) <3 h = 150 (136-165)3-4.5 h = 150 (136-166) p = 0.007
DBP (mmHg) 90 (80-104) <3 h = 81 (74-90)3-4.5 h = 80 (74-90) p<0.001p<0.001
NIHSS 16 (10-20) <3 h = 12 (7-17)3-4.5 h = 10 (6-15) p<0.001p<0.001
Glycemia (mg/dL) 114 (101-162) <3 h = 117 (102-140)3-4.5 h = 117 (103-142) p = 0.011p = 0.011

SITS-ISTR: Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Registry. NA: not available. SBP: systolic blood pressure at the time of admission. DBP: diastolic blood pressure at the time of admission. NIHSS: National Institutes of Health Stroke Scale. Categorical variables are shown as relative frequencies (%). Numerical variables are shown as medians (interquartile range).